Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is approved for AMA PRA Category 1 Credit™.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
This activity is supported by an educational grant from Athenex.
37th Annual CFS®: Innovative Cancer Therapy for Tomorrow® — Call for Poster Abstracts!
The Program Chairs and Steering Committee invite you to submit your abstracts for the 37th Annual CFS®: Innovative Cancer Therapy for Tomorrow®, to be held November 6-8, 2019, at the New York Marriott Marquis in Times Square, New York, NY.
Deadline for submission is Friday, October 4, 2019.
All poster abstract submissions must be made electronically through the PER® online abstract submission system.
The abstract should be a short description of your work and should contain all of the elements necessary to define your goals and results for the reader, and include the components of the abstract body listed below. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. However, the formal poster session is not designated for credit.
Share your research or best practices with your peers. Categories of submission include:
The Program Chairs and Steering Committee will evaluate the scientific quality of the submitted abstracts based on the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed.
Notification of acceptance or regret will be delivered via e-mail to the presenters of each poster abstract by mid-October. Please note that an author is required to be present during the poster session. If accepted for presentation, abstracts and posters will be available for viewing online on the 2019 CFS® website during and after the conference. A formal poster viewing will be held during the conference in the Exhibit Hall, where breakfast and refreshment breaks will also be held. The presentation at the conference should reflect the submitted abstract; abstract title, authorship, and content of the presentation must match the submitted abstract.
All presenters must register to attend the 37th Annual CFS®: Innovative Cancer Therapy for Tomorrow®.
Components of the abstract body – Limit: 2500 characters (1 table allowed)
Please submit any questions pertaining to abstract submissions to firstname.lastname@example.org using the subject line “CFS Abstract QUESTION.”
Author Consent and Waiver of Claims
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Multiple Myeloma
Feb 28, 2019
Feb 28, 2019
Feb 28, 2019
23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
February 28, 2019 - March 3, 2019